Artificial intelligence (AI) is revolutionizing drug discovery by providing novel and efficient ways to identify potential therapeutic compounds. The process of discovering new drugs is […]
Venture Round – Causeway Sensors
On Mar 15, 2022 Causeway Sensors closed a Venture – Series Unknown round and raised £1,500,000 from Kernel Capital, QUBIS, featuring lead investors Kernel Capital. […]
Series B – Arima Genomics
On Mar 15, 2022 Arima Genomics closed a Series B round and raised $7,000,000 from Agilent Technologies, Berkeley Catalyst Fund (BCF), Cowin Venture, Genetron Health, […]
Series B – Molecular Assemblies
On Mar 15, 2022 Molecular Assemblies closed a Series B round and raised $25,800,000 from Agilent Technologies, Argonautic Ventures, Casdin Capital, Codexis, iSELECT FUND, LYFE […]
Series A – Eclipse Bioinnovations
On Mar 15, 2022 Eclipse Bioinnovations closed a Series A round and raised $14,000,000 from Alexandria Venture Investments, iGlobe, Phoenix Venture Partners, Photon Venture Alpha, […]
Venture Round – PrognomiQ
On Mar 15, 2022 PrognomiQ closed a Venture – Series Unknown round and raised $46,000,000 from aMoon Fund, Bruker, Catalio Capital Management, Emerson Collective, Fidelity […]
Seed Round – AiM Medical Robotics
On Mar 15, 2022 AiM Medical Robotics closed a Seed round and raised $3,400,000 from IQ Capital, Surrey Capital Partners, The Lambda Funds, Triple Ring […]
Venture Round – Causeway Sensors
On Mar 15, 2022 Causeway Sensors closed a Venture – Series Unknown round and raised £1,500,000 from Kernel Capital, QUBIS, featuring lead investors Kernel Capital. […]
Corporate Round – Emollivet
On Mar 15, 2022 Emollivet closed a Corporate Round round and raised SEK5,000,000 from Lipidor AB, featuring lead investors Lipidor AB. About the company: Emollivet […]
Seed Round – BLOK London
On Mar 15, 2022 BLOK London closed a Seed round and raised €4,450,000 from ACF Investors, Crowdcube, Elcot Capital, Future Fund, Rob Glaser, The Santon […]
